firstgeneration antidepressant Antidepressants third most common cause of drugrelated fatalities cyclic antidepressants the most commonly identified class of antidepressants to cause overdoserelated ID: 909019
Download Presentation The PPT/PDF document "EPIDEMIOLOGY TCA & MAOI" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Slide2EPIDEMIOLOGY
TCA & MAOI
first-generation antidepressant.Antidepressants third most common cause of drug-related fatalities .
cyclic antidepressants
the most commonly identified class of antidepressants to cause overdose-related deaths.!
Slide3Slide4Slide5Slide6PHARMACOKINETICS
peak plasma levels :
between 2 and 6 hours Tissue cyclic antidepressant levels :
10 to 100
times greater than plasma levels.
Attempts to remove cyclic antidepressants by hemodialysis,hemoperfusion,
peritoneal dialysis, or forced diuresis generally are
unproductive.
Slide7The average half-life of cyclic antidepressants
24 hours (range, 6 to 36 hours).
Slide8TOXICITY
patients at
higher risk for cyclic antidepressant toxicity include who have medication such as:Cardiotoxic
Sedative-hypnotic
Geriatric
patients, underlying heart or neurologic
disease.
Slide9Desipramine
Most potent sodium channel blocker
Precipitate severe cardiotoxicity (e.g.,
wide QRS
complex,
hypotension) It is associated with a higher fatality rate
than the other cyclic antidepressants
Slide10Amoxapine
and maprotiline
Associated with greater toxicity than other cyclic antidepressants, especially in regard to causing seizures.
Slide11CLINICAL FEATURES
Mild
antimuscarinic symptoms: (dry mouth and
axillae,sinus
tachycardia)
Severe cardiotoxicity secondary to sodium channel blockade.
Slide12Most common symptom
:
Altered mental status.
(GCS of <8 in the ED
is a strong predictor of serious complications such as
seizures and cardiac dysrhythmias
)Most frequent dysrhythmia:
Sinus tachycardia.
Slide13Serious toxicity
within
6 hours of major cyclic antidepressant
ingestion and consists of:
coma
cardiac conduction delays supraventricular
tachycardia hypotension respira
tory depression ventricular tachycardia
seizures
Slide14Secondary complications
Apiration
pneumoniaAnoxic encephalopathyHyperthermia.
Rhabdomyolysis
.
Pulmonary edema
Slide15Seizures
Generalized and of brief duration.
Exception : amoxapine
and
maprotiline
(these agents can cause status epilepticus.)
Slide16DIAGNOSIS
Urine tests
Cannot differentiate between therapeutic and toxic levels. False positive results have been reported for a number of medications such as :
carbamazepine
. cetirizine, cyclobenzaprine
. cyproheptadine. diphenhydramine
, hydroxyzine. quetiapine.
phenothiazines
(e.g.•
thioridazine
).
Slide17ECG abnormalities
The classic ECG with cyclic antidepressant
toxicity:(sinus tachycardia
,
right axis deviation
and prolongation of the PR,QRS. and QT intervals)
Slide18ECG abnormalities
develop within
6 hours of ingestion and typically resolve over 36 to
48
hr.
The identification of either QRS complex widening of >100 ms, right axis deviation of > 120 degrees, or a
Brugada pattern warrants sodium bicarbonat
therapy and admission to a ICU.
Slide19Slide20Slide21Slide22Slide23Slide24TREATMENT
Evaluation for
: alterations of consciousness.
hemodynamic instability
respiratory impairment.
IV line Continuous cardiac rhythm monitoring
Serial ECGs laboratory studies (electrolyte. creatinine. and glucose level)
Serum acetaminophen level ABG
Slide25Antimuscarinic
symptoms
: urinary catheterization nasogastric
tube
Patients who are initially asymptomatic may deteriorate rapidly and therefore should be
monitored closely for 6 hours.
Slide26GI DECONTAMINATION
ipecac syrup cannot be recommended
charcoal
single 1 gram/kg dose.
gastric lavage
Slide27• SODIUM BICARBONATE THERAPY:
Indications:
- Hypotension refractory to fluid hydration.
-
Cardiac conduction abnormalities
(e.g., prolonged QRS duration or Brugada pattern), -Ventricular
dysrhythmias.
Slide28SODIUM BICARBONATE THERAPY
IV bolus of
1 to 2 mEq/kg.
which can be repeated until patient
improvement
is noted or until blood pH equals 7.50 to 7.55
Slide29ALTERED LEVEL OF CONSCIOUSNESS
Coma
is rapid in onset and serves as a predictive factor for development of cardiotoxicity and/or seizures.Flumazenil
Reassurance. decreased environmental stimulation. and benzodiazepines.
Physostigmine
Slide30SEIZURES
Seizures are
generalized and of brief duration.Focal seizures are atypical and should prompt further neurologic evaluation.
Seizures are common with
maprotiline
& amoxapine ingestions and require aggressive management. Because status epilepticus
is frequently associated with them.
Slide31Benzodiazepines
( diazepam,
lorazepam) are the anticonvulsants of
choice
to stop existing seizure activity
Seizures resistant to benzodiazepine: Barbiturates(e.g .•
phenobarbital)Endotracheal intubation and respiratory support are required when benzodiazepines are combined with barbiturates or
propofol.
Slide32HYPOTENSION
1..Treated with isotonic crystalloid fluids in IV boluses
10 ml/kg.2.. does not improve:
sodium bicarbonate
3.. does not improve:
vasopressor most effective:
norepinephrine (1 microgram/min to 30 micrograms/min.)
Slide33CARDIAC CONDUGION ABNORMALITIES
AND DYSRHYTHMIAS
Asymptomatic patients with
sinus tachycardia
,
isolated PR interval prolongation or first-degree atrioventTicular block do not require specific pharmacologic therapy.
Slide34Asymptomatic or mildly toxic patients with
isolated QRS complex prolongation
(QRS duration is > 100 milliseconds) should be treated with sodium bicarbonate
therapy.
Hyperventilation Hypertonic saline
Slide35Ventricular
dysrhythmias
: sodium bicarbonatesecond agent of choice: Lidocaine
Slide36Contraindicated medications
all class
Ia and Ic antiarrhythmic
agents,
B blockers Calcium channel blockers
all class III antiarrhythmic agents.
Slide37Intravenous lipid emulsion:
20% lipid emulsion 100 mL IV bolus
over 1 minute. followed by 400
mL
IV over 20 minutes in patients with life-thTeatening cyclic antidepressant induced cardiotoxicity that is refractory to other measures
Slide38DISPOSITION AND FOLLOW-UP
Asymptomatic after 6 hours
of observation do not require hospital admission for toxicologic reasons.
All symptomatic patients :
hospital admission
.signs of moderate to severe toxicity: ICU
Slide39